1. Home
  2. ALT vs LASR Comparison

ALT vs LASR Comparison

Compare ALT & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • LASR
  • Stock Information
  • Founded
  • ALT 1997
  • LASR 2000
  • Country
  • ALT United States
  • LASR United States
  • Employees
  • ALT N/A
  • LASR N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • LASR Semiconductors
  • Sector
  • ALT Health Care
  • LASR Technology
  • Exchange
  • ALT Nasdaq
  • LASR Nasdaq
  • Market Cap
  • ALT 472.3M
  • LASR 412.8M
  • IPO Year
  • ALT N/A
  • LASR 2018
  • Fundamental
  • Price
  • ALT $4.14
  • LASR $19.31
  • Analyst Decision
  • ALT Strong Buy
  • LASR Strong Buy
  • Analyst Count
  • ALT 6
  • LASR 5
  • Target Price
  • ALT $20.20
  • LASR $17.70
  • AVG Volume (30 Days)
  • ALT 10.1M
  • LASR 960.3K
  • Earning Date
  • ALT 08-07-2025
  • LASR 07-31-2025
  • Dividend Yield
  • ALT N/A
  • LASR N/A
  • EPS Growth
  • ALT N/A
  • LASR N/A
  • EPS
  • ALT N/A
  • LASR N/A
  • Revenue
  • ALT $20,000.00
  • LASR $205,689,000.00
  • Revenue This Year
  • ALT N/A
  • LASR $13.20
  • Revenue Next Year
  • ALT $1,557,547.90
  • LASR $8.66
  • P/E Ratio
  • ALT N/A
  • LASR N/A
  • Revenue Growth
  • ALT N/A
  • LASR 2.66
  • 52 Week Low
  • ALT $2.90
  • LASR $6.20
  • 52 Week High
  • ALT $11.16
  • LASR $19.99
  • Technical
  • Relative Strength Index (RSI)
  • ALT 33.67
  • LASR 74.14
  • Support Level
  • ALT $3.30
  • LASR $16.87
  • Resistance Level
  • ALT $4.04
  • LASR $19.95
  • Average True Range (ATR)
  • ALT 0.61
  • LASR 0.87
  • MACD
  • ALT -0.40
  • LASR -0.09
  • Stochastic Oscillator
  • ALT 19.49
  • LASR 89.33

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.

Share on Social Networks: